1 / 18

MediWales

MediWales. June 2014. IP Group Share Price. Gold. The FTSE All Share Index. A house in Cardiff. £325. £171. £234. £330. Traditional US Life Science Venture Performance. Looking at it in a different way……. Source: Nesta. UK Private Equity and Venture Returns 1996:2012.

tambre
Download Presentation

MediWales

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MediWales June 2014

  2. IP Group Share Price Gold The FTSE All Share Index A house in Cardiff

  3. £325 £171 £234 £330

  4. Traditional US Life Science Venture Performance

  5. Looking at it in a different way…… Source: Nesta

  6. UK Private Equity and Venture Returns 1996:2012 Source: PwC BVCA Private Equity and Venture Capital Performance Measurement Survey 2012

  7. The UK has a world class Life Science Sector Glasgow Manchester Nottingham Cambridge Oxford Kings / Cambridge UK scientists awarded over 70 Nobel Prizes Rated as best Euro location for bioscience, healthcare / medical and clinical research Is the leading the G8 for research productivity The UK has 31 of the worlds top 200 Universities Four of the world’s top ten universities for life sciences are in the UK

  8. Business Model Exclusive access to IP from leading research universities 1 2 3 Incubate and test with as little cash as possible Back the winners with cash and people Disclosures Incubation Seed “Post-seed” Stage of development Aim to deploy as little capital as possible Aim to increase level of capital deployed as risk profile reduces 30% 70% 100% 3% 1.5% 1%

  9. Portfolio track record – IP Group

  10. Acquisition of Fusion IP plc and £100M placing

  11. Life Science Portfolio Personalised Medicine: Biomarkers and Diagnostics Vaccines and Biologics Drug Discovery Products and Services E-tect SAW Diagnostics Regenerative Medicine Small Molecule Therapeutics Medical Devices Oxsybio Healthcare IT Life Science Instrumentation

  12. Why there is so much excitement around ONT From the mainframe To the laptop To the USB stick “We will be telling our grandchildren that we used to do sequencing in specialist buildings with big machines – they’ll never believe us” “This represents the democratisation of sequencing”

  13. Tissue Regenix Group plc Successful IPO in June 2010 Significant press coverage Regenerative common body soft tissue parts Vascular grafts Vascular patch Dialysis access Shoulder (rotator cuff) Cardiac patch Heart valves Bladder Bypass graft Knee ligament (cruciate) Meniscus Blood vessels Ankle • Advanced woundcare product DermaPure reimbursement approved in the US • Additional programmes in Cardiac, Orthopaedics and Vascular • Going from strength to strength

  14. Medaphor Limited Bye-bye mannequins Sales! Virtual reality ultrasound training in a growing market • Saves time, money and resources for hospitals and training centres, Cross-application potential • 100 Systems sold globally to date

  15. Asalus Medical Instruments Limited Winners of the Cutlers’ Surgical Prize and Praxis Unico award The Problem Surgical smoke is a significant issue during laparoscopic surgery Disruptive in a £300M market • Based on electrostatic precipitation, a highly effective means of removing airborne particulates • Recently CE marked and now available in 15 countries • £4M in equity financing to date

  16. MediWales June 2014

More Related